Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
@article{Bourhis2006HyperfractionatedOA, title={Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis}, author={Jean Bourhis and Jens Overgaard and H{\'e}l{\`e}ne Audry and Kian K. Ang and Mi Saunders and Jacques Bernier and Jean Claude Horiot and Aur{\'e}lie Le Ma{\^i}tre and Thomas F. Pajak and Michael Poulsen and Brian O'Sullivan and Werner Dobrowsky and Andrzej Hliniak and Krzysztof Składowski and John H. Hay and Luiz H. J. Pinto and Carlo Fallai and Karen K. Fu and Richard J. Sylvester and Jean Pierre Pignon}, journal={The Lancet}, year={2006}, volume={368}, pages={843-854} }
997 Citations
Hyperfractionated or accelerated radiotherapy for head and neck cancer.
- MedicineThe Cochrane database of systematic reviews
- 2010
Comparison of the different types of altered radiotherapy suggests that hyperfractionation provides the greatest benefit, which was particularly efficient in reducing local failure, whereas the benefit on nodal control was less pronounced.
Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.
- Medicine, BiologyJournal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2012
Patients with nonmetastatic NSCLC derived a significant OS benefit from accelerated or hyperfractionated radiotherapy; a similar but nonsignificant trend was observed for SCLC; as expected, there was increased acute esophageal toxicity.
A Randomized Prospective Study of Concurrent Chemo-Radiotherapy vs Accelerated Hyperfractionation in Advanced Cancer of Head and Neck.
- MedicineJournal of clinical and diagnostic research : JCDR
- 2016
The present study suggests that AHF should be preferred over CRT in locally advanced, unresectable, squamous cell head and neck cancer followed over three months non-treatment period.
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
- MedicineThe Lancet. Oncology
- 2017
Hyperfractionated radiotherapy with concurrent docetaxel for advanced head and neck cancer: a phase II study.
- MedicineAnticancer research
- 2012
This modality is a valuable treatment option for the management of locally-advanced head and neck squamous cell cancer and should be considered for further study.
Hyperfractionated Accelerated Radiotherapy versus Conventional Fractionation Both Combined with Chemotherapy in Patients with Locally Advanced Head and Neck Carcinomas
- MedicineOncology
- 2009
There was no trend towards an improved efficacy of HART in comparison with CFRT in combination with CC, and the prognostic value of these pretreatment factors did not variate with the fractionation schedule used.
“ Hypofractionated Accelerated Radiotherapy Compared with Conventional Radiotherapy of Squamous Cell Carcinoma of Head and Neck with Concurrent Cisplatin ”
- Medicine
- 2017
The hypofractionated regimen was associated with increased but tolerable acute and late morbidities, and the reduction in number of fractions and treatment time allows more efficient use of resources.
Prospective Study to Compare Conventional Radiotherapy with Hypofractionated Radiotherapy in Locally Advanced Carcinoma of Oral Cavity
- Medicine
- 2020
Hypofractionated radiotherapy has a comparable response to conventional radiotherapy with slight more acute and late but manageable treatment related toxicity with significantly reduced treatment time.
The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
- MedicineClinical oncology (Royal College of Radiologists (Great Britain))
- 2011
Hypofractionated accelerated radiotherapy in T1-3 N0 cancer of the larynx: A prospective cohort study with historical controls.
- MedicineReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
- 2016
References
SHOWING 1-10 OF 27 REFERENCES
A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer.
- MedicineRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- 1997
Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
- MedicineRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- 2000
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.
- MedicineInternational journal of radiation oncology, biology, physics
- 2003
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
- MedicineThe Lancet
- 2000
A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.
- MedicineRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- 1997
Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial.
- Medicine, PhysicsJournal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2006
The very accelerated RT regimen was feasible and provided a major benefit in locoregional control but had a modest effect on survival.
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
- MedicineRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- 1997
Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.
- MedicineInternational journal of radiation oncology, biology, physics
- 1991
Impact of age on treatment effect in locally advanced head and neck cancer (HNC): Two individual patient data meta-analyses.
- MedicineJournal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2006
Treatment benefit decreases with increasing age, and patients aged 71+ did not benefit from Alt- RT nor from concomitant CT in MACH-NC, a study considering age as a potential modifier of the treatment effect.
A multicentre randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time.
- MedicineRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- 2002